Inteliquet^™, an
IQVIA Business

Marie E. Lamont is the general manager of Inteliquet, an IQVIA business. With a goal of ensuring physicians and their patients have access to the latest and best clinical trials, she focuses Inteliquet’s technology enablement on facilitating decision-making and reducing the administrative burden for research centers and healthcare institutions.

With more than 25 years as a global healthcare, data and biotech leader, Marie has significant commercial and operational expertise. Prior to Inteliquet, Marie headed up an executive consulting and advisory firm for the life sciences and healthcare digital technology industries. Before her consultancy, Marie was president of the Patient Services business at Dohmen Life Science Services, which was subsequently sold and is now part of EVERSANA. Prior to DLSS, Marie was global head of Business Strategy and Commercial Operations for Rare Disease at Sanofi Genzyme. She had stewardship of the $2.9 billion business for which the annual operating profit improved at a rate greater than revenue. She also led humanitarian programs that provided free therapy for more than 1,100 patients suffering from rare diseases in emerging markets. Prior to this position, she took on an integration assignment as vice president of integration for Finance and Accounting following the Sanofi acquisition of Genzyme. Before this assignment, she was vice president of Operations & Finance for the International Group, where the business grew from $100 million in 2002 to $2 billion at the time of the Sanofi acquisition. She guided the operational strategy for the international infrastructure on a regional and country basis for the Oncology, Transplant, Renal, Biosurgery and Rare Disease business units.

Marie holds a bachelor’s degree in Business from Saint Michael’s College in Colchester, Vt., and attended Harvard Business School and Kellogg Executive Education programs. She lives in the St. Louis, Mo., area.

“Early on, I was fortunate to work for a CEO who believed that when you treat patients and employees right, business success follows — and you can change the world. I believe this applies to every employee in any role, whether patient-facing or not,” Marie says.

“My grandfather passed due to lung cancer. I saw how the cycle of disease progression and therapy can be a horrid emotional journey for everyone involved. When considering a new role, I evaluate whether I can make a difference to patients now or in the future. Since Inteliquet can harness the best data to rapidly identify and qualify patients for trials, we have a significant opportunity to benefit patients, improve health outcomes and advance the standard of care in oncology and beyond.”

As Inteliquet’s Managing Director of Cancer Center Support Services, Jeanie leads a team of experienced clinical researchers in the delivery of value-driven support services to our Cancer Center Consortium partners – ensuring the optimization of trial operations essential to the patient enrollment process.

With over 15 years of direct clinical experience in oncology, Jeanie is an accomplished clinical research solutions expert. A renowned strategic innovator and thought leader, Jeanie has crafted an impressive career creating new opportunities through forging cross-cultural and cross-functional collaborative alliances and partnerships, delivering highly effective and impactful solutions in Life Sciences and healthcare.

Prior to joining Inteliquet, Jeanie served as Vice President of Research Strategy at Temple University Healthcare System: Fox Chase Comprehensive Cancer Center. Providing leadership and oversight over all aspects of research operations and business administration, she contributed to the development of programs and processes that reflected commitment to the cancer center support grant, which maintained Fox Chase its status as an NCI-designated institution.  Jeanie was also Director of Clinical Research at NYU Langone Medical Center, where she performed annual portfolio assessments to initiate conversations around long-term growth and moved the operating budget from a negative to a positive cash flow in a nine-month period, achieving the first ever FY Operating Margin for long-standing Administrative Program.

As Management Consultant and Director of Operations at AstraZeneca Subsidiary: Aptium East NY, Jeanie revamped the research compliance framework for the Outpatient Clinical Cancer Center, which involved multiple divisions, including Medical, Surgical, Radiation, Radiology and Psychiatry, breaking down silos and supporting an Outcome-based care delivery.

A well-known and deeply respected Thought and Key Opinion Leader, Jeanie generously contributes multiple presentations, publications, and initiatives as a Clinical Research Solutions expert. She also presents and lectures at accredited oncology nursing programs, multi-disciplinary educational meetings, and client-sponsored events.

Jeanie earned an Associate of Science degree in Nursing, graduating Summa Cum Laude from the University of the State of New York, and a Bachelor of Science degree in Health Administration, graduating Summa Cum Laude with the distinction of Salutatorian, from St. Joseph’s College, where she was also a member of Kappa Gamma Pi. She additionally holds a C.W. Post, MBA with Cum Laude honors, from Long Island University, where she was also a member of the National Business Honor Society and Delta Mu Delta. Jeanie also holds a Coaching Certificate from New York University and a Lean Six-Sigma Greenbelt.

“As our cancer knowledge evolves, the greater ideas we generate for providing patients and their physicians with an improved palette of treatment options. The suite of solutions offered by Inteliquet supports the drive to match those diagnosed with cancer to cutting-edge trials. Importantly, this includes affording additional access points to underserved and previously underrepresented people. I am thrilled to join this team, at the intersection of healthcare and technology, as we speed to meet the needs of the oncology community.”

Kirk Junker is responsible for all aspects of software development and operations to create, test, deploy, and manage Inteliquet’s Clinical Consortium. He oversees teams of software engineers, operations engineers, and data engineers responsible for the production operations, which include matching patients for clinical trials and providing clinical trial feasibility assessment. He joined Inteliquet as Director of Engineering in 2011.
Kirk has more than 25 years of experience in all aspects of strategic technology solutions and architecture, design, development, implementation consulting services, and program management experience. He is familiar with solutions surrounding protected health information, de-identifying patient information, master patient index, and the integration of patient data systems for analytics.

Kirk has expertise and leadership experience designing large, complex data warehouses and data integration solutions as well as commercial software products.  He has designed genomics database solutions and worked with clinical informatics protocols in the biomedical industry.  Prior to Inteliquet, Kirk founded Toscana Solutions, LLC, a software and consulting services company that used open source products to implement effective and affordable data warehouse, business intelligence, predictive analytics, data integration and data visualization solutions. Among the products he designed and developed were a predictive analytics solution for a large hospital to improve efficiency of scheduling; patient management and billing systems; and an online application that provided patients a genetic analysis of their cancer tissue from a genotype along with drug data and research to provide a recommended treatment plan.

Prior to Toscana Solutions, Kirk was a member of the senior management team for a leading-edge technical services firm managing the growth of a software services organization for up to 170 consultants and alliance partners.  His responsibilities included all aspects of delivery operations, budgeting, business development, and engagement management. His previous work experience also includes the role Director of Innovation for the RDA Corporation, where he oversaw a portfolio of software development engagements, while also responsible for developing new products, services, and revenue generating opportunities. His past professional experience also included three years as an Application Developer for Arthur Andersen, LLP.

Kirk received his Bachelor of Science in business finance from Virginia Polytechnic Institute and State University in Blacksburg, Virginia.

Ambre Chevalier is Director, Marketing and Communications and is responsible for supporting Inteliquet’s business and Cancer Center Consortium growth through outreach, thought leadership and other marketing activities. She believes we have great opportunity to bring patients, sites, and sponsors together in a concerted effort to save lives, time, and costs.

Previously, Ambre led the marketing launch of the Orchestrated Clinical Trials platform and its supporting AI-driven Clinical Data Analytics Suite at IQVIA, establishing a reputation as an industry digital transformation disruptor. Ambre has held roles leading marketing and enablement teams at Oracle, Medidata, and Sun Microsystems. Her work has encompassed national patient indexes, health information exchange, data models and analytics, and translational research technology. As a rare disease patient advocate, Ambre’s focus works across healthcare and life sciences to relieve inefficiencies and resultant frustrations in the care continuum that benefit from patient-centric technology.

Ambre earned a bachelor’s degree in education and special education from Prescott College, founding a curriculum software company as a culmination of her studies. She holds a Master of Business Administration with a concentration in healthcare management from the Western Governors University. In her spare time, Ambre enjoys hosting tea with friends, practicing foreign language study with her daughter, and taking drives with her husband in one of their restored classic cars.

John Pappa is the Associate Director of Applied Data Services at Inteliquet, an IQVIA business. He’s responsible for managing the primary Life Sciences clinical data asset and driving business revenue from derivative works. John oversees Real-World Data license sales, production of synthetic cohorts, and retrospective chart review projects. He supports the larger IQVIA Real-World Services organization by leveraging the Life Sciences data asset and associated services. He’s responsible for creating, validating, and supporting both internal and external client data feeds and manages a technical team that supports these monthly real-world data operations.

John is a value-centric technology leader who specializes in aligning solutions design, delivery, support, and professional services with strategic business objectives. With over twenty-five years of experience developing and managing software, he has worked with numerous software and systems technologies and processes, spanning commercial and custom software development, project and program management, clinical operations, and professional services management. John has also worked in precision medicine, including automated clinical trial matching, data integration, healthcare and business analytics, client engagement management, and enterprise integration architectures.

John has developed embedded systems, led R&D projects, developed mission-critical aerospace systems, and managed the development of both ISV software and large-scale IT systems. Previously, he was the VP of Engineering at Catapulse, Director of RSG Engineering at Rational Software, WW Manager of Internal Deployment at IBM, Senior Development Manager at Enertech Consultants, and Scientific Programmer at Lockheed.

John used his strong healthcare and IT experience in working with the executive leadership team to identify key business metrics and KPIs that needed to be tracked and utilize the business development team to expand relationships with potential Life Sciences and BioPharma and Pharma companies who would benefit from leveraging real-world data and services.

Betsy is the Director of Cancer Center Support Services at Inteliquet, an IQVIA company. Ensuring that all Inteliquet consortium members reach their research goals through improved patient matching and feasibility, Betsy focuses on comprehensive support for consortium member staff, from training and monitoring of metrics to integrating platform feedback for improved research workflows and development of new NLP/ML tools.

Betsy brings over fifteen years of clinical research experience with a specialty in hematology and oncology. She’s built multiple clinical programs into large operations, enrolling hundreds of patients per year and generating millions in annual revenue, in both academic and community settings. As part of the Metro MN Community Oncology Consortium (an NCORP grant program), she worked across multiple healthcare networks on NCI and sponsored trials in support of expanding patient access to clinical research. Many of these trials exceeded sponsor enrollment requirements and performed well in audits, both from sponsors and the FDA, making MMCORC a highly sought-after partner throughout the oncology research arena. As part of a pilot NGS testing platform, Betsy provided a mechanism for free tumor biomarker testing for thousands of patients annually. The program underwent significant operational improvement under Betsy’s leadership, transitioning both IRB oversight to a central model and regulatory operations to a tech-enabled platform. Before joining MMCORC, Betsy managed the Hematology program at the Carbone Cancer Center at the University of Wisconsin-Madison. Under her, the program grew to offer trials to patients with hematologic malignancies, including those undergoing bone marrow transplants. Collaborating with clinical and bench researchers, Betsy developed a bone marrow tissue bank at both UW and the adjacent Madison VA Hospital. Several IIT’s developed within this group were able to expand enrollment to the Wisconsin Oncology Network, providing patients throughout the state to access new treatment options.

Betsy attended the University of Wisconsin-Madison for both her undergraduate and graduate work, with degrees in molecular biology and public health. She lives in Minneapolis.

Brian Cargill is responsible for the Software Development and Operations teams creating and deploying Inteliquet’s Clinical Consortium software. He joined Inteliquet as a Senior Software Engineer in 2012. Before joining Inteliquet, Brian held multiple roles and led teams at SAIC, TriSept, and RDA Consultants. These roles ranged from leading analysis efforts and architecting solutions to managing software development teams and QA staff. He also participated as Lead Technologist in sales efforts for several large projects at SAIC and TriSept.

Brian has more than twenty-five years of experience in all aspects of the software development lifecycle, from architecture design to deployment and maintenance. He has worked in the insurance, finance, healthcare, and aerospace industries. Professionally, Brian’s roots are in software development, having written his first program at age twelve and being self-taught ever since. Regardless of his role, he has always been involved in delivering modern software solutions.

Vassia Roulia serves as the Inteliquet Clinical Business Development Lead. She’s an experienced and innovative professional with demonstrated leadership in strategic decision-making, site management, and business operations in multi-facility healthcare organizations, academic medical centers, and community practices. Vassia is skilled in all aspects of clinical research operations from Phase I–IV, BioPharma-sponsored, and investigator-initiated trials as well as various therapeutic areas with an emphasis in oncology, CNS, and dermatology. Vassia has more than twenty-five years of experience fostering industry relations with big pharma organizations, CROs, community partnerships, and institutions, supporting clinical and translational research initiatives.

Before joining Inteliquet, Vassia served as the Executive Director of Envision Research, a clinical site management organization. Before this appointment, she was the Vice President for Research Development and Administration of the Biomedical Research Foundation (BRF) and Chief Research Officer of BRF’s University Health System in Northern Louisiana. Previously, she served in senior administrative positions as the Director of the Clinical Neurobiology and Bioengineering Research Center and Founder / Director of the Office of Grants Strategy Development and Administration at Banner Good Samaritan Medical Center. She also provided scientific and business leadership at Scottsdale Healthcare’s Clinical Research Institute and served as the Business Director of the Barrow Neurological Institute at Phoenix Children’s Hospital. Before moving to Arizona, Vassia held clinical research positions in the Dermatology and Neurology departments at the University of Michigan, University of Florida, and Gainesville’s VA Medical Center.

Vassia holds a B.S. in Chemistry with a minor in Biochemistry and an M.S. in Pharmacology as a National Institutes of Health (NIH) fellow—both from the University of Michigan in Ann Arbor, Michigan. She earned her executive MBA at the University of Florida. Vassia is an ACRP-certified professional.

Judith Woods is an eClinical technology professional with a passion for innovating and maximizing the impact of clinical trial systems, applications, and processes. She previously served in the positions of Associate Director of Client Technology, Senior Quality Manager, and Manager of the Technical Learning Group at Parexel International. She was also a consultant to the following clinical trial vendors and researchers: HealthCore, Signant Health, Symfo, and Phase V Technologies. In December 2020, Judith joined our team as Operations Manager of Cancer Center Support Services.

Judith has expertise in risk-based monitoring, eCOA/ePRO, and client-facing patient-matching platforms. She helps Inteliquet identify current and future trends in clinical trials, develop mentoring programs to help our staff become internal and external consultants, strategize ways to improve platform performance and increase utilization through pilot programs. She continues to leverage analytics to influence the success of our platform and team.